Center-Authored Papers

Filters: Author is Phelan, Catherine M  [Clear All Filters]
Journal Article
White KL, Vierkant RA, Fogarty ZC, Charbonneau B, Block MS, Pharoah PDP, Chenevix-Trench G, Rossing MA, Cramer DW, Pearce CL et al..  2013.  Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(5):987-92. Abstract
Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK et al..  2016.  Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.. Oncotarget. Abstract
Lawrenson K, Li Q, Kar S, Seo J-H, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R et al..  2015.  Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.. Nature communications. 6:8234. Abstract
Chornokur G, Lin H-Y, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai Y-Y, Jim HSL, Chen Z et al..  2015.  Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.. PloS one. 10(6):e0128106. Abstract
Jim HSL, Lin H-Y, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KKH et al..  2015.  Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).. Journal of genetics and genome research. 2(2) Abstract
Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM et al..  2015.  Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer.. Carcinogenesis. 36(11):1341-1353. Abstract
Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP et al..  2014.  Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.. Molecular nutrition & food research. Abstract
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC et al..  2013.  Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.. Nature communications. 4:1628. Abstract
Amankwah EK, Lin H-Y, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KKH, Anton-Culver H, Antonenkova N, Bruinsma F et al..  2015.  Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.. Genetic epidemiology. Abstract
Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ, Chenevix-Trench G et al..  2015.  Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.. Gynecologic oncology. 136(3):542-8. Abstract
Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, Defazio A, Gava N, Webb PM, Rossing MA et al..  2010.  Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".. PLoS genetics. 6(7):e1001016. Abstract
Permuth JB, Pirie A, Chen AY, Lin H-Y, Reid BM, Chen Z, Monteiro A, Dennis J, Mendoza-Fandino G, Anton-Culver H et al..  2016.  Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.. Human molecular genetics. Abstract
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK et al..  2016.  Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.. Nature communications. 7:12675. Abstract
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA et al..  2013.  Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.. Human genetics. Abstract
Rebbeck TR, Devesa SS, Chang B-L, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM et al..  2013.  Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent.. Prostate cancer. 2013:560857. Abstract
Pharoah PDP, Tsai Y-Y, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H et al..  2013.  GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.. Nature genetics. 45(4):362-70,370e1-2. Abstract
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin H-Y, Chen AY, Tsai Y-Y, Qu X et al..  2013.  Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.. Nature communications. 4:1627. Abstract
Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G et al..  2017.  Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.. Nature genetics. Abstract
Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, Agata S, Ahsan H et al..  2016.  Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.. Nature communications. 7:11375. Abstract
Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, Freeman A, Hopper JL et al..  2016.  Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.. Breast cancer research : BCR. 18(1):64. Abstract
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM et al..  2015.  Identification of six new susceptibility loci for invasive epithelial ovarian cancer.. Nature genetics. 47(2):164-71. Abstract
Permuth JB, Reid B, Earp M, Chen AY, Monteiro ANA, Chen Z, Chen Z, Chenevix-Trench G, Fasching PA, Beckmann MW et al..  2016.  Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.. Oncotarget. 7(45):72381-72394. Abstract
Gu F, Zhang H, Hyland PL, Berndt S, Gapstur SM, Wheeler W, Amos CI, Bezieau S, Bickeböller H, Brenner H et al..  2017.  Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.. International journal of cancer. Abstract
Reid BM, Permuth JB, Chen AY, Teer JK, Monteiro ANA, Chen Z, Tyrer J, Berchuck A, Chenevix-Trench G, Doherty JA et al..  2017.  Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26(1):116-125. Abstract
Winham SJ, Pirie A, Chen YA, Larson MC, Fogarty ZC, Earp MA, Anton-Culver H, Bandera EV, Cramer D, Doherty JA et al..  2016.  Investigation of exomic variants associated with overall survival in ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract